We are live on ! Find out more
BIOT

Biotech Acquisition Company Class A Ordinary Shares

Delisted

BIOT was delisted on the 2nd of February, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
CCP
1
Corbin Capital Partners
New York
$9.04M
SCM
2
Saba Capital Management
New York
$8.81M +$3.05M +315,057 +53%
Citadel Advisors
3
Citadel Advisors
Florida
$8.77M +$20.4K +2,108 +0.2%
PC
4
Periscope Capital
Ontario, Canada
$7.4M -$1.94K -200 -0%
LA
5
Linden Advisors
New York
$6.61M
MI
6
MMCAP International
Cayman Islands
$5.84M
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$5.84M
SRCM
8
Sage Rock Capital Management
New York
$5.59M +$5.56M +573,800 New
ACM
9
Atalaya Capital Management
New York
$5.42M
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$5.16M +$3.36M +346,182 +189%
Blackstone Inc
11
Blackstone Inc
New York
$4.87M
DCM
12
DG Capital Management
New York
$4.38M
DKCM
13
Davidson Kempner Capital Management
New York
$4.38M +$554K +57,202 +15%
RCM
14
Radcliffe Capital Management
Pennsylvania
$3.95M
FTCM
15
Fir Tree Capital Management
New York
$3.92M +$28.2K +2,905 +0.7%
Nomura Holdings
16
Nomura Holdings
Japan
$3.89M
Hudson Bay Capital Management
17
Hudson Bay Capital Management
Connecticut
$3.8M
Marshall Wace
18
Marshall Wace
United Kingdom
$3.08M +$2.09M +216,038 +216%
MP
19
Mangrove Partners
Connecticut
$2.92M
SC
20
Sculptor Capital
New York
$2.92M
ACA
21
Arena Capital Advisors
California
$2.92M +$1.96M +202,728 +208%
Deutsche Bank
22
Deutsche Bank
Germany
$2.44M
CC
23
Centiva Capital
New York
$2.42M
Goldman Sachs
24
Goldman Sachs
New York
$2.28M -$5.82K -600 -0.3%
RCM
25
Rivernorth Capital Management
Florida
$2.19M +$2.18M +224,998 New